Memo commences Phase I trial of antibody against BKV infection - Clinical Trials Arena
5/31/2022 12:00:00 AM2 years 11 months ago
by Vishnu Priyan
by Vishnu Priyan
Memo Therapeutics has commenced a Phase I clinical trial to assess its therapeutic antibody candidate MTX-005 in healthy adult subjects to potentially treat BK polyomavirus (BKV) infection in renal tr
Memo Therapeutics has commenced a Phase I clinical trial to assess its therapeutic antibody candidate MTX-005 in healthy adult subjects to potentially treat BK polyomavirus (BKV) infection in renal t… [+1963 chars]
full article...